Cynthia L. Rakestraw
FDA investigator
Appears on 2 documents from 2014, mostly at sites in Pennsylvania. Most often cites control of microbiological contamination (21 CFR 211.113(b)).
- 2
- Documents on file
- 5.0
- Observations per 483
- 2014
- First seen
- 2014
- Most recent
What they cite most
From 5 observations- 21 CFR 211.113(b)Control of microbiological contamination2
- 21 CFR 211.165(a)Testing and release for distribution1
- 21 CFR 211.166(b)Stability testing1
- 21 CFR 211.167(a)Special testing requirements1
Activity by year
2014: 2
Where
Pennsylvania 2
Often inspects with
Is Cynthia L. Rakestraw coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2014-10-07 | Response Hieber's PharmacyOct 7, 2014 · Pittsburgh, Pennsylvania | Pittsburgh, Pennsylvania | — | |
| 2014-09-18 | 483 Hieber’s PharmacySep 18, 2014 · Pittsburgh, Pennsylvania | Pittsburgh, Pennsylvania | 5 |
About this profile
What does Cynthia L. Rakestraw inspect?
Cynthia L. Rakestraw appears on 2 documents on file covering 1 site, mostly in Pennsylvania.
What do they cite most often?
21 CFR 211.113(b) (control of microbiological contamination), followed by 21 CFR 211.165(a) and 21 CFR 211.166(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Cynthia L. Rakestraw is dated Oct 7, 2014.